Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Evaluation of the Effects of Canagliflozin on Renal and Cardiovascular Outcomes in Participants With Diabetic Nephropathy

ClinicalTrials.gov ID: NCT02065791

Public ClinicalTrials.gov record NCT02065791. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 4, 2026, 9:38 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-blind, Event-driven, Placebo-controlled, Multicenter Study of the Effects of Canagliflozin on Renal and Cardiovascular Outcomes in Subjects With Type 2 Diabetes Mellitus and Diabetic Nephropathy

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The goal of this study is to assess whether canagliflozin has a renal and vascular protective effect in reducing the progression of renal impairment relative to placebo in participants with type 2 diabetes mellitus (T2DM), Stage 2 or 3 chronic kidney disease (CKD) and macroalbuminuria, who are receiving standard of care including a maximum tolerated labeled daily dose of an angiotensin-converting enzyme inhibitor (ACEi) or angiotensin receptor blocker (ARB).

Study identification

NCT ID
NCT02065791
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Enrollment
4,401 participants

Conditions and interventions

Eligibility (public fields only)

Age range
30 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 17, 2014 (Actual)
Primary completion
Oct 30, 2018 (Actual)
Completion
Oct 30, 2018 (Actual)
Last update posted
Dec 5, 2019

2014 – 2018

United States locations

U.S. sites
152
U.S. states
37
U.S. cities
152
Facility City State ZIP Site status
Not listed Birmingham Alabama — —
Not listed Montgomery Alabama — —
Not listed Tempe Arizona — —
Not listed Tucson Arizona — —
Not listed Little Rock Arkansas — —
Not listed Sherwood Arkansas — —
Not listed Bakersfield California — —
Not listed Chula Vista California — —
Not listed Covina California — —
Not listed Downey California — —
Not listed Fountain Valley California — —
Not listed Hawthorne California — —
Not listed Inglewood California — —
Not listed Laguna Hills California — —
Not listed Lakewood California — —
Not listed Long Beach California — —
Not listed Los Angeles California — —
Not listed Lynwood California — —
Not listed Northridge California — —
Not listed Oakland California — —
Not listed Orange California — —
Not listed Pasadena California — —
Not listed Roseville California — —
Not listed Sacramento California — —
Not listed Salinas California — —
Not listed San Diego California — —
Not listed San Dimas California — —
Not listed Stanford California — —
Not listed Tustin California — —
Not listed Whittier California — —
Not listed Denver Colorado — —
Not listed Golden Colorado — —
Not listed Lakewood Colorado — —
Not listed Washington Colorado — —
Not listed Washington D.C. District of Columbia — —
Not listed Coral Springs Florida — —
Not listed Doral Florida — —
Not listed Hialeah Florida — —
Not listed Jacksonville Florida — —
Not listed Miami Florida — —
Not listed Miami Springs Florida — —
Not listed North Miami Beach Florida — —
Not listed Ocala Florida — —
Not listed Port Charlotte Florida — —
Not listed St. Petersburg Florida — —
Not listed Winter Park Florida — —
Not listed Atlanta Georgia — —
Not listed Augusta Georgia — —
Not listed Columbus Georgia — —
Not listed Roswell Georgia — —
Not listed Snellville Georgia — —
Not listed Stockbridge Georgia — —
Not listed Chicago Illinois — —
Not listed Crystal Lake Illinois — —
Not listed Gurnee Illinois — —
Not listed Mount Prospect Illinois — —
Not listed Winfield Illinois — —
Not listed Fort Wayne Indiana — —
Not listed Indianapolis Indiana — —
Not listed Merrillville Indiana — —
Not listed Michigan City Indiana — —
Not listed Muncie Indiana — —
Not listed Council Bluffs Iowa — —
Not listed Louisville Kentucky — —
Not listed Paducah Kentucky — —
Not listed Kenner Louisiana — —
Not listed Rockport Maine — —
Not listed Scarborough Maine — —
Not listed Annapolis Maryland — —
Not listed Baltimore Maryland — —
Not listed Beltsville Maryland — —
Not listed Hyattsville Maryland — —
Not listed Silver Spring Maryland — —
Not listed Boston Massachusetts — —
Not listed Plymouth Massachusetts — —
Not listed Springfield Massachusetts — —
Not listed Worcester Massachusetts — —
Not listed Flint Michigan — —
Not listed Jackson Mississippi — —
Not listed Chesterfield Missouri — —
Not listed Kansas City Missouri — —
Not listed St Louis Missouri — —
Not listed Fremont Nebraska — —
Not listed Lincoln Nebraska — —
Not listed Omaha Nebraska — —
Not listed Reno Nebraska — —
Not listed Las Vegas Nevada — —
Not listed Eatontown New Jersey — —
Not listed Albuquerque New Mexico — —
Not listed Albany New York — —
Not listed Binghamton New York — —
Not listed Buffalo New York — —
Not listed Great Neck New York — —
Not listed Lake Success New York — —
Not listed New Hyde Park New York — —
Not listed New York New York — —
Not listed Ridgewood New York — —
Not listed Riverhead New York — —
Not listed Smithtown New York — —
Not listed Springfield Gardens New York — —
Not listed Asheville North Carolina — —
Not listed Calabash North Carolina — —
Not listed Charlotte North Carolina — —
Not listed Durham North Carolina — —
Not listed Greensboro North Carolina — —
Not listed Greenville North Carolina — —
Not listed High Point North Carolina — —
Not listed Morehead City North Carolina — —
Not listed Morganton North Carolina — —
Not listed Raleigh North Carolina — —
Not listed Tabor City North Carolina — —
Not listed Whiteville North Carolina — —
Not listed Cincinnati Ohio — —
Not listed Columbus Ohio — —
Not listed Maumee Ohio — —
Not listed Roseburg Oregon — —
Not listed Beaver Pennsylvania — —
Not listed Bethlehem Pennsylvania — —
Not listed Philadelphia Pennsylvania — —
Not listed Pittsburgh Pennsylvania — —
Not listed Anderson South Carolina — —
Not listed Columbia South Carolina — —
Not listed Lancaster South Carolina — —
Not listed Murrells Inlet South Carolina — —
Not listed Orangeburg South Carolina — —
Not listed Sumter South Carolina — —
Not listed Chattanooga Tennessee — —
Not listed Knoxville Tennessee — —
Not listed Memphis Tennessee — —
Not listed Arlington Texas — —
Not listed Corpus Christi Texas — —
Not listed Corsicana Texas — —
Not listed Dallas Texas — —
Not listed Edinburg Texas — —
Not listed Fort Worth Texas — —
Not listed Houston Texas — —
Not listed Mesquite Texas — —
Not listed San Antonio Texas — —
Not listed Schertz Texas — —
Not listed Sugar Land Texas — —
Not listed Temple Texas — —
Not listed Waco Texas — —
Not listed Salt Lake City Utah — —
Not listed Bennington Vermont — —
Not listed Burlington Vermont — —
Not listed Bluefield Virginia — —
Not listed Mechanicsville Virginia — —
Not listed Norfolk Virginia — —
Not listed Suffolk Virginia — —
Not listed Spokane Washington — —
Not listed Huntington West Virginia — —
Not listed Milwaukee Wisconsin — —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 423 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02065791, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 5, 2019 · Synced Nov 4, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT02065791 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →